Castle Creek Arbitrage, LLC - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 15 filers reported holding UNITED THERAPEUTICS CORP DEL in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Castle Creek Arbitrage, LLC ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q1 2015$141,990,000
+33.0%
39,384,0000.0%7.20%
+40.6%
Q4 2014$106,758,000
+0.6%
39,384,0000.0%5.12%
-17.3%
Q3 2014$106,078,000
+80.3%
39,384,000
+26.2%
6.19%
+66.1%
Q2 2014$58,823,000
-5.0%
31,200,0000.0%3.72%
+16.0%
Q1 2014$61,948,000
+26.1%
31,200,000
+50.7%
3.21%
+49.0%
Q4 2013$49,114,000
+39.6%
20,700,0000.0%2.16%
+36.9%
Q3 2013$35,185,000
+56.0%
20,700,000
+33.5%
1.57%
+53.9%
Q2 2013$22,561,00015,500,0001.02%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q4 2014
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders